Brief: Aravive To Present Phase 1B Data Evaluating AVB-500 In Platinum Resistant Ovarian Cancer

Aravive

12/03/2021 12:43

March 12 (Reuters) - Aravive Inc  ARAV.O :
    * ARAVIVE TO PRESENT PHASE 1B DATA EVALUATING AVB-500 IN
PLATINUM
RESISTANT OVARIAN CANCER AT 2021 SOCIETY OF GYNECOLOGIC ONCOLOGY
ANNUAL MEETING

Source text for Eikon:  ID:nGNX4qCZgd 
Further company coverage:  ARAV.O 

 ((Reuters.Briefs@thomsonreuters.com;))